Clinical Trials Directory

Trials / Completed

CompletedNCT01522014

Randomized Clinical Trial of Ceramic Bearing Primary Total Hip Arthroplasty

Five-Year Outcome of Ceramic on Ceramic Bearing Versus Ceramic on Crossfire® Highly Cross-Linked Polyethylene Bearing in Primary Total Hip Arthroplasty: A Randomized Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
92 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Primary total hip arthroplasty (THA) has been a very successful surgical intervention in the geriatric population. Numerous studies have reported good mid and long term results of THA in patients over the age of 60 years. With the reported high success rate of this surgical intervention, the THA surgery is being performed in younger patients who have significant joint disease. A clinical trial, using a randomized blinded design, was undertaken to compare the functional outcome of 1) alumina heads/alumina liners, and 2) alumina head/Crossfire polyethylene liners in patients 60 years of age or younger with non-inflammatory arthritis of the hip. Subjects were assessed preoperatively and at one and five years postoperatively. Ten-year follow-up is currently underway. The primary outcome measure is the WOMAC Osteoarthritis Index. Secondary measures were the RAND-12, as well as measurement of complication and revision rates. The patient's demand on the implant as calculated by the patient's age, weight, health status and activity level was also measured.

Conditions

Interventions

TypeNameDescription
DEVICESecure-Fit™ arc-deposited Hydroxylapatite (HA) shell - surface ceramic and an Alumina Bearing Couple (ABC) ceramic insert and Ceramic C-taper head
DEVICESecure-Fit™ arc-deposited hydroxylapatite shell, a Crossfire® insert and a Ceramic C-taper head

Timeline

Start date
1997-11-01
Primary completion
2009-01-01
Completion
2009-06-01
First posted
2012-01-31
Last updated
2021-07-28

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT01522014. Inclusion in this directory is not an endorsement.